Suppression of Androgen Action and the Induction of Gross Abnormalities of the Reproductive Tract in Male Rats Treated Neonatally With Diethylstilbestrol
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
This study evaluated whether androgen action is altered in rats treated neonatally with diethylstilbestrol (DES) at a dose that induced reproductive tract abnormalities. Rats were treated on alternate days 2–12 with 10 μg DES and studied on Day 18. DES‐induced abnormalities included a 70% reduction in testis weight, distension and overgrowth of the rete, distension and reduction in epithelial height of the efferent ducts, underdevelopment of the epididymal duct epithelium, reduction in epithelial height in the vas deferens, and convolution of the extra‐epididymal vas. In DES‐treated rats, androgen receptor (AR) immunoexpression was virtually absent from all affected tissues and the testis, whereas AR expression in controls was intense in epithelial and stromal cells. The DES‐induced change in AR immunoexpression was confirmed by Western analysis for the testis. In rats treated neonatally with 1 μg DES, reproductive abnormalities were absent or minor, except for a 38% reduction in testis weight; loss of AR immunoexpression also did not occur in these rats. Treatment‐induced changes in AR expression were paralleled by changes in Leydig cell volume per testis (91% reduction in the 10‐μg DES group; no change in the 1‐μg DES group). To test whether suppression of androgen production or action alone could induce comparable reproductive abnormalities to 10 μg DES, rats were treated neonatally with either a potent gonadotropin‐releasing hormone antagonist (GnRHa) or with flutamide (50 mg/kg/day). These treatments reduced testis weight (68% for GnRHa, 40% for flutamide), and generally retarded development of the reproductive tract but failed to induce the abnormalities induced by 10 μg DES. GnRHa and flutamide caused no detectable change in AR immunoexpression in target tissues, with the exception of minor changes in the testes of flutamide‐treated males. GnRHa treatment caused a reduction (83%) in Leydig cell volume comparable to that caused by 10 μg DES. Immunoexpression of estrogen receptor alpha (ERα) in the efferent ducts and of ERβ in all tissues studied were unaffected by any of the above treatments. Neonatal coadministration of testosterone esters (TE; 200 μg) with 10 μg DES prevented most of the morphological abnormalities induced by 10 μg DES treatment alone, though testis weight was still subnormal (46% reduction in DES + TE vs 72% in DES alone and 49% with TE alone) and some lumenal distension was still evident in the efferent ducts. Coadministration of TE with DES prevented DES‐induced loss of AR immunoexpression (confirmed for testis by Western blot analysis). It is concluded that 1) reproductive tract abnormalities induced in the neonatal male rat by a high (10 μg) dose of DES are associated with reduced AR expression and Leydig cell volume; 2) these changes are largely absent with a lower dose of DES (1 μg); 3) treatments that interfere with androgen production (GnRHa) or action (flutamide) alone failed to induce reproductive tract abnormalities or alter AR expression as did 10 μg DES; 4) a grossly altered androgen:estrogen balance (low androgen + high estrogen) may underlie the reproductive tract abnormalities, other than reduced testis weight, induced by high doses of DES.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mylchreest, E., Sar, M., Cattley, R. C., & Foster, P. M. D. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8643 · Cited by 440
Male Reproductive Health and Environmental Xenoestrogens
Toppari, J., Larsen, J. C., Christiansen, P., Giwercman, A., Grandjean, P., Guillette, L. J., Jegou, B., Jensen, T. K., Jouannet, P., Keiding, N., et al. (1996) · Environmental Health Perspectives · doi:10.2307/3432709 · Cited by 348
Self-citationSaunders, P. T. K., Millar, M. R., Williams, K., Macpherson, S., Harkiss, D., Anderson, R. A., Orr, B., Groome, N. P., Scobie, G., & Fraser, H. M. (2000) · Biology of Reproduction · doi:10.1095/biolreprod63.4.1098 · Cited by 175
Self-citation
Cited by
EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1010 · Cited by 2,407
State-of-the-science of endocrine disrupting chemicals, 2012
Bergman, Å., Heindel, J., Jobling, S., Kidd, K., & Zoeller, R. T. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.03.020 · Cited by 1,388
O’Donnell, L., Robertson, K. M., Jones, M. E., & Simpson, E. R. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.3.0431 · Cited by 757
Epigenetic Transgenerational Actions of Endocrine Disruptors
Anway, M. D., & Skinner, M. K. (2006) · Endocrinology · doi:10.1210/en.2005-1058 · Cited by 455
Fisher, J. S. (2004) · Reproduction · doi:10.1530/rep.1.00025 · Cited by 427
Self-citation
Metadata
- Authors
- McKINNELL, C., ATANASSOVA, N., WILLIAMS, K., FISHER, J. S., WALKER, M., TURNER, K. J., SAUNDERS, P. T. K., & SHARPE, R. M.
- Venue
- Journal of Andrology
- Publisher
- Wiley
- Published
- 2001-03-04
- Volume
- 22
- Issue
- 2
- Pages
- 323-338
- ISSN
- 0196-3635 (ISSN-L)
- 1939-4640
- OpenAlex
- W270625501
- Cited by
- 152
- References
- 3
- FWCI
- 10.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Suppression of Androgen Action and the Induction of Gross Abnormalities of the Reproductive Tract in Male Rats Treated Neonatally With Diethylstilbestrol. https://app.cochat.ai/papers/10.1002/j.1939-4640.2001.tb02186.x
- The paper
- McKINNELL, C., ATANASSOVA, N., WILLIAMS, K., FISHER, J. S., WALKER, M., TURNER, K. J., SAUNDERS, P. T. K., & SHARPE, R. M. (2001). Suppression of Androgen Action and the Induction of Gross Abnormalities of the Reproductive Tract in Male Rats Treated Neonatally With Diethylstilbestrol. Journal of Andrology. https://doi.org/10.1002/j.1939-4640.2001.tb02186.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.